LC
BIIB icon

Lindbrook Capital’s Biogen BIIB Stock Holding History

Lindbrook Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$151K Buy
1,100
+476
+76% +$68K 0.01% 512
2024
Q4 		$95.4K Buy
624
+32
+5% +$5.4K 0.01% 573
2024
Q3 		$115K Sell
592
-135
-19% -$28.2K 0.01% 526
2024
Q2 		$169K Buy
727
+186
+34% +$40.4K 0.02% 394
2024
Q1 		$117K Hold
541
– – 0.01% 493
2023
Q4 		$140K Sell
541
-81
-13% -$19.9K 0.01% 427
2023
Q3 		$160K Sell
622
-91
-13% -$24.3K 0.02% 367
2023
Q2 		$203K Buy
713
+14
+2% +$4.17K 0.02% 321
2023
Q1 		$194K Buy
699
+130
+23% +$36K 0.02% 319
2022
Q4 		$158K Buy
569
+47
+9% +$13.3K 0.02% 385
2022
Q3 		$139K Buy
522
+77
+17% +$16.4K 0.02% 354
2022
Q2 		$91K Sell
445
-239
-35% -$48.9K 0.02% 462
2022
Q1 		$144K Buy
684
+202
+42% +$43.9K 0.02% 366
2021
Q4 		$116K Buy
482
+236
+96% +$60.7K 0.02% 453
2021
Q3 		$70K Sell
246
-93
-27% -$30.5K 0.02% 350
2021
Q2 		$117K Buy
339
+111
+49% +$33.6K 0.03% 256
2021
Q1 		$64K Buy
228
+30
+15% +$8.09K 0.01% 366
2020
Q4 		$48K Sell
198
-12
-6% -$3.1K 0.01% 408
2020
Q3 		$60K Sell
210
-16
-7% -$4.46K 0.02% 310
2020
Q2 		$60K Sell
226
-38
-14% -$11.4K 0.02% 322
2020
Q1 		$84K Buy
264
+29
+12% +$8.8K 0.03% 210
2019
Q4 		$70K Buy
235
+17
+8% +$4.72K 0.02% 340
2019
Q3 		$51K Sell
218
-5
-2% -$1.16K 0.02% 411
2019
Q2 		$52K Sell
223
-994
-82% -$230K 0.02% 411
2019
Q1 		$287K Buy
1,217
+43
+4% +$13.5K 0.11% 89
2018
Q4 		$353K Buy
+1,174
New +$375K 0.17% 62

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lindbrook Capital's BIIB Position: Q1 2025 in Review

Lindbrook Capital increased its Biogen (BIIB) stake by 76% in Q1 2025, buying an estimated $68K and bringing the position to 1,100 shares worth $151K. The position accounts for 0.01% of the portfolio, ranked #512.

Lindbrook Capital first reported a position in BIIB in Q4 2018 and has held it in 26 quarters since. The position peaked at $353K in Q4 2018. 882 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • Lindbrook Capital held 1,100 shares of Biogen worth $151K as of Q1 2025.
  • Lindbrook Capital bought 476 Biogen shares in Q1 2025, an estimated $68K.
  • Biogen made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #512 holding.
  • Lindbrook Capital first reported a position in Biogen in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's Biogen position peaked at $353K in Q4 2018.
  • 882 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.